Peeling Back The Layers: Exploring Apellis Pharmaceuticals Through Analyst Insights
Peeling Back The Layers: Exploring Apellis Pharmaceuticals Through Analyst Insights
剝離層層: 通過分析師的洞察，探索Apellis Pharmaceuticals
Across the recent three months, 12 analysts have shared their insights on Apellis Pharmaceuticals (NASDAQ:APLS), expressing a variety of opinions spanning from bullish to bearish.
在最近的三個月裏，12位分析師分享了他們對Apellis製藥公司（NASDAQ:APLS）的見解，表達了從看好到看淡的各種觀點。
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
下表提供了他們最近評級的精簡視圖，顯示了過去30天的不同情緒，並將其與前幾個月進行比較。
The 12-month price targets, analyzed by analysts, offer insights with an average target of $76.17, a high estimate of $100.00, and a low estimate of $46.00. A 6.77% drop is evident in the current average compared to the previous average price target of $81.70.
經由分析師評估的12個月價格目標，提供了一個平均目標爲76.17美元，高估爲100.00美元，低估爲46.00美元的見解。當前平均價格目標比先前的81.70美元的目標價格下降了6.77%。
Exploring Analyst Ratings: An In-Depth Overview
分析師評級:深入了解
The analysis of...
對近期...
登入免費觀看全文
登入/註冊
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。